Michael Barnes discusses the Trump Administration’s opioid policies, warning that, unless the Food and Drug Administration changes its course, no new forms of the gold-standard medication for opioid addiction will come to market before 2024.
Attorney & Policy Advisor
Michael Barnes discusses the Trump Administration’s opioid policies, warning that, unless the Food and Drug Administration changes its course, no new forms of the gold-standard medication for opioid addiction will come to market before 2024.